During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of ...

By carefully selecting codon combinations, researchers can improve protein expression, reduce mRNA degradation, and enhance stability. This also impacts protein folding, post-translational ...

Wall Street is off to a volatile start in 2025, with investors stepping on the sell pedal after last week's jobs data, followed by a sharp about-face in sentiment following Wednesday's consumer ...

mRNA vaccines have emerged as a major scientific ... and challenges such as systemic delivery leading to rapid degradation by nucleases, macrophage phagocytosis removal, and renal filtration ...

Detailed price information for Biovaxys Technology Corp (BVAXF) from The Globe and Mail including charting and trades.